News
The jabs have been reported to have fuelled a ‘baby boom’, with women saying online they have had ‘Ozempic babies’ despite ...
A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...
WOMEN on fat jabs must take effective contraception, health chiefs have warned for the first time. It comes amid claims of an ‘Ozempic baby boom’ – with more women becoming pregnant while ...
Some Blue Cross and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs, then ...
GLP-1 users taking drugs like Ozempic and Wegovy are spending less on eating at restaurants and on take-out dinners, ...
Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
Body mass index (BMI) has long been a common tool for estimating a person's relative weight status based on a simple height to weight ratio. It's easy to calculate, widely accessible and often used ...
Four clinical organizations jointly release an advisory with evidence-based nutrition and lifestyle interventions to enhance ...
A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results